Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 349,130 | 433,074 | 83,366 | 99,814 | 249,588 |
| Marketable Securities | 139,675 | 100,335 | 119,918 | 121,613 | 53,235 |
| Receivables | 3,243 | 1,717 | N/A | N/A | N/A |
| TOTAL | $496,777 | $540,225 | $208,249 | $227,089 | $305,633 |
| Non-Current Assets | |||||
| PPE Net | 20,710 | 15,932 | 11,896 | 11,419 | 9,653 |
| Investments And Advances | 13,233 | 0 | 16,139 | 39,440 | 0 |
| Other Non-Current Assets | 95,723 | 97,437 | 85,606 | 24,326 | 24,921 |
| TOTAL | $129,666 | $113,369 | $113,641 | $75,185 | $34,574 |
| Total Assets | $626,443 | $653,594 | $321,890 | $302,274 | $340,207 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 13,932 |
| Accounts payable and accrued liabilities | 3,717 | 13,563 | 5,173 | 5,822 | 5,715 |
| Accrued Expenses | 14,782 | 11,618 | 11,770 | 14,697 | 13,843 |
| Other current liabilities | 16,245 | 3,160 | 3,160 | 2,808 | 2,106 |
| TOTAL | $54,195 | $45,322 | $24,924 | $27,806 | $40,595 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 17,121 | 14,626 | 2,923 | 2,787 | 3,367 |
| Other Non-Current Liabilities | 98,505 | 79,473 | 74,624 | 25,937 | 27,074 |
| TOTAL | $147,883 | $134,161 | $77,748 | $29,712 | $31,570 |
| Total Liabilities | $202,078 | $179,483 | $102,672 | $57,518 | $72,165 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87,244 | 86,844 | 77,692 | 75,931 | 75,593 |
| Common Shares | 87 | 87 | 76 | 76 | 75 |
| Retained earnings | -503,821 | -445,137 | -417,065 | -383,545 | -355,243 |
| Other shareholders' equity | 315 | 626 | 145 | 25 | 54 |
| TOTAL | $424,365 | $474,111 | $219,218 | $244,756 | $268,042 |
| Total Liabilities And Equity | $626,443 | $653,594 | $321,890 | $302,274 | $340,207 |